DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Mold-Tek Technologies Limited — Press Release

NSE 9 hrs ago·6 Aug 2026, 8:49 am

Mold-tek Technologies

Mold-Tek Technologies Limited has announced a press release, dated August 06, 2026, which has been submitted to the stock exchange. The company has not yet disclosed the specific content or subject matter of the communication.

For investors, this development is noteworthy as it signals that the company has a material update to share with the market. The lack of specific details means the stock's reaction will likely depend on the nature of the information once it is made public.

Investors should wait for the full text of the press release to understand the implications. Monitoring the company's official filings will provide clarity on how this news might impact the company's future outlook and stock performance.